Assessment of Serum Uric Acid Levels According to Sex and Stage for Patients with Alzheimer-type Dementia
Journal Title: UNKNOWN - Year 2019, Vol 25, Issue 2
Abstract
Objective: The aim of this study was to identify serum uric acid (UA) concentrations according to disease stage in patients with Alzheimer-type dementia (AD), and to collect data related to the hypothesis that oxidative stress is effective on the etiopathogenesis and progression of disease stage. Materials and Methods: The study was conducted with 180 patients who were categorized into disease stages in accordance with the Clinical Dementia Rating Scale (CDR) and 150 healthy individuals of the same age group. In our retrospective study, patients who showed more than one cognitive deficit and diagnosed with possible AD according to the diagnostic criteria of National Institute of Neurological and Communicative Disorders and Stroke-Alzheimer’s Disease and Related Disorders Association were administered the CDR, Mini-Mental Test (MMSE), Geriatric Depression Rating Scale (GDRS), and individuals in the control group were administered the MMSE and GDRS. Venous blood samples for biochemical studies were collected after 12-14 hours of fasting in the patient and control groups. Results: In patients diagnosed as having AD, it was found that there was a statistically significant increase in age and duration of disease parallel with the progression of disease stages, and a decrease in UA and albumin concentrations in both males and females (p<0.05). Conclusion: Our study supports the hypothesis that the decrease detected in serum UA concentrations in parallel with the progression of disease stages is directly related to the pathogenesis of AD. For the identification of chronic progressive diseases such as AD and to take precautions, the identification of variations in easily accessible and low-cost parameters such as serum albumin and UA concentrations in the early stages becomes important. In future years, when neuroprotective and neuro-restorative treatment options are available, identification of serum UA values as a marker of disease progression and knowledge of the association between serum UA concentrations and disease stage in our data will guide and support research into disease etiology.
Authors and Affiliations
Tamer Yazar, Hülya Olgun Yazar
Keywords
Related Articles
- EP ID EP581145
- DOI 10.4274/tnd.galenos.2019.85698
- Views 69
- Downloads 0
Management and Early Treatment of Status Epilepticus in Adults and Children
Status epilepticus (SE) is one of the most frequent neurologic emergencies. Generalized convulsive SE, which is the most frequent and easily recognized type of SE, has the highest morbidity and mortality rates. It is imp...
Evaluation of C-reactive Protein/Albumin Ratio According to Stage in Patients with Idiopathic Parkinson Disease
Objective: Identification of serum C-reactive protein (CRP)/albumin ratio according to disease stage in idiopathic Parkinson’s disease (IPD) with the aim of collecting data about the role of inflammation and oxidative st...
Following the 52nd National Neurology Congress
.
Raeder’s Syndrome “Paratrigeminal Neuralgia” Beyond Headache: A Case Report
Raeder’s syndrome (paratrigeminal neuralgia), which sometimes radiates to the maxillary section, is defined as a constant and unilateral pain in the distribution area of the ophthalmic branch of the trigeminal nerve acco...
Fingolimod for the Treatment of Relapsing-Remitting Multiple Sclerosis
Multiple sclerosis (MS) is a chronic autoimmune disease of the central nervous system and is characterized by inflammation, demyelination, and axonal loss. Fingolimod is the first oral drug for the treatment of MS approv...